Výsledky vyhledávání - "Thiazoles/therapeutic use"

Possible treatment and strategies for COVID-19:review and assessment

Autor: Trivedi, N, Verma, A, Kumar, D

Publikováno v: Trivedi, N, Verma, A & Kumar, D 2020, ' Possible treatment and strategies for COVID-19 : review and assessment ', European review for medical and pharmacological sciences, vol. 24, no. 23, pp. 12593-12608 . https://doi.org/10.26355/eurrev_202012_24057

The coronavirus disease 2019 (COVID-19) is declared as an international emergency in 2020. Its prevalence and fatality rate are rapidly increasing but the medication options are still limited for this perilous disease. The emergent outbreak of COVID-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3818::67e7992fccea44928baf508273a43c1b
https://www.research.manchester.ac.uk/portal/en/publications/possible-treatment-and-strategies-for-covid19(6314579b-9634-4e58-a745-0862e56f0f85).html

Zobrazit plný text záznamu

Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease

Publikováno v: De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Collet, J-P, Halvorsen, S, Huber, K, Jespersen, J, Kristensen, S D, Lip, G Y H, Morais, J, Rasmussen, L H, Ricci, F, Sibbing, D, Siegbahn, A, Storey, R F, Ten Berg, J, Verheugt, F W A & Weitz, J I 2016, ' Oral anticoagulants in coronary heart disease (Section IV) : Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease ', Thrombosis and Haemostasis, vol. 115, no. 4, pp. 685-711 . https://doi.org/10.1160/TH15-09-0703
Thrombosis and Haemostasis, 115, 4, pp. 685-711
De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Collet, J-P, Halvorsen, S, Huber, K, Jespersen, J, Dalby Kristensen, S, Lip, G Y H, Morais, J, Rasmussen, L H, Ricci, F, Sibbing, D, Siegbahn, A, Storey, R F, Ten Berg, J, Verheugt, F W A & Weitz, J I 2016, ' Oral anticoagulants in coronary heart disease (Section IV) : Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease ', Thrombosis and Haemostasis, vol. 115, no. 4, pp. 685-711 . https://doi.org/10.1160/TH15-09-0703
Thrombosis and Haemostasis, 115, 685-711
De Caterina, R, Husted, S, Wallentin, L, Andreotti, F, Arnesen, H, Bachmann, F, Baigent, C, Collet, J-P, Halvorsen, S, Huber, K, Jespersen, J, Kristensen, S D, Lip, G Y H, Morais, J, Rasmussen, L H, Ricci, F, Sibbing, D, Siegbahn, A, Storey, R F, Ten Berg, J, Verheugt, F W A & Weitz, J I 2016, ' Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease ', Thrombosis and Haemostasis, vol. 115, no. 4, pp. 685-711 . https://doi.org/10.1160/TH15-09-0703

SummaryUntil recently, vitamin K antagonists (VKAs) were the only available oral anticoagulants evaluated for long-term treatment of patients with coronary heart disease (CHD), particularly after an acute coronary syndrome (ACS). Despite efficacy in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df839339f412ec880dd78b90f94fcce
https://doi.org/10.1160/th15-09-0703

Zobrazit plný text záznamu

Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization

Autor: Yoshikawa, Nami, Noda, Kousuke, Ozawa, Yoko, Tsubota, Kazuo, Mashima, Yukihiko, Ishida, Susumu

Publikováno v: Molecular vision. 18:593-600

Purpose: Vascular adhesion protein (VAP)-1 is an adhesion molecule elucidated as a mediator of the leukocyte recruitment cascade. The purpose of this study was to investigate the role of VAP-1 in ocular inflammatory neovascularization using a mouse l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::dbd91fc75e6eeb53447d1920c1ae3a4b
http://hdl.handle.net/2115/54617

Zobrazit plný text záznamu

Sparsom evidens for antipsykotika til behandling af organisk delirium

Autor: Andersen, Charlotte U, Høimark, Lene, Dabrowski, Karol, Hansen, Kenneth Brandt, Sædder, Eva

Publikováno v: Andersen, C U, Høimark, L, Dabrowski, K, Hansen, K B & Sædder, E 2014, ' Sparsom evidens for antipsykotika til behandling af organisk delirium ', Ugeskrift for Laeger, bind 176, nr. 20, V11130658, s. 1858-1862 . < https://ugeskriftet.dk/videnskab/sparsom-evidens-antipsykotika-til-behandling-af-organisk-delirium >

Traditionally, haloperidol has been the recommended antipsychotic drug for pharmacological treatment of delirium, which is a frequent complication in the critical care setting. Due to a less frequent occurrence of extrapyramidal adverse effects, seco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::1d49a7093f0a28254c82a5bb8d78f86d
https://pure.au.dk/portal/da/publications/sparsom-evidens-for-antipsykotika-til-behandling-af-organisk-delirium(574888f0-19fd-4666-b31a-49588f42cee0).html

Zobrazit plný text záznamu

Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy

Autor: Alexandra Calmy, Bernard Hirschel, Didier Hans, Véronique L Karsegard, Christoph A Meier

Publikováno v: AIDS, Vol. 17, No 5 (2003) pp. 770-772

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b76e463def0999ed62615532d07799
https://pubmed.ncbi.nlm.nih.gov/12646807

Zobrazit plný text záznamu

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies

Autor: Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., Leibowitz, M.D., Colombel, J.F., Auwerx, J.

Publikováno v: The Journal of Experimental Medicine
Journal of Experimental Medicine, vol. 193, no. 7, pp. 827-838

The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in the colon mucosa and its activation has been reported to protect against colitis. We studied the involvement of PPARgamma and its heterodimeric partner, the retin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b6de24a8930be457509016df0afa9970
https://pubmed.ncbi.nlm.nih.gov/11283155

Zobrazit plný text záznamu

Effects of the PPAR-β agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination

Autor: Marie-Gabrielle Zurich, Paul Honegger, Antoinette Defaux, Olivier Braissant, Florianne Monnet-Tschudi

Publikováno v: Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 6, Iss 1, p 15 (2009)
Journal of Neuroinflammation, vol. 6, pp. 15

Background Brain inflammation plays a central role in numerous brain pathologies, including multiple sclerosis (MS). Microglial cells and astrocytes are the effector cells of neuroinflammation. They can be activated also by agents such as interferon-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6bc13768a26d20458c63bb67e3520d1
http://europepmc.org/articles/PMC2687435

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání